Compare ARK Genomic Revolution ETF (ARKG) vs Uranium Energy Corp (UEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Uranium Energy Corp — how do they compare? ARK Genomic Revolution ETF trades at $40.55, while Uranium Energy Corp trades at $10.07 (market cap $5.21B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Uranium Energy Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | UEC | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $43.57 | $20.14 |
52-Week Low | $23.09 | $6.59 |
Market Cap | — | $5.21B |
Enterprise Value | — | $4.72B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
UEC trades at $10.53, up 3.64% today, but technical indicators show a bearish trend with strong selling pressure. The company reported widening losses with negative net income margins and zero revenue in recent quarters, though it maintains $794 million in liquid assets and no debt. Analyst consensus remains overwhelmingly bullish with 87.5% buy ratings, citing strategic positioning in uranium production.
Investment outlook hinges on execution of production ramp-ups and uranium price recovery. Key opportunities include strategic assets and strong liquidity, while risks involve persistent losses, regulatory delays, and volatile commodity prices. The stock faces near-term pressure from weak fundamentals despite long-term nuclear energy tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Uranium Energy Corp
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →
